{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:22:16Z","timestamp":1790626936366,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000781","name":"EC | European Research Council","doi-asserted-by":"publisher","award":["322749"],"award-info":[{"award-number":["322749"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"EC | European Research Council","doi-asserted-by":"publisher","award":["322749"],"award-info":[{"award-number":["322749"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"EC | European Research Council","doi-asserted-by":"publisher","award":["322749"],"award-info":[{"award-number":["322749"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"EC | European Research Council","doi-asserted-by":"publisher","award":["322749"],"award-info":[{"award-number":["322749"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"EC | European Research Council","doi-asserted-by":"publisher","award":["322749"],"award-info":[{"award-number":["322749"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"EC | European Research Council","doi-asserted-by":"publisher","award":["322749"],"award-info":[{"award-number":["322749"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"EC | European Research Council","doi-asserted-by":"publisher","award":["322749"],"award-info":[{"award-number":["322749"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fibro\/Adipogenic Progenitors (FAPs) define a stem cell population playing a pro-regenerative role after muscle damage. When removed from their natural niche, FAPs readily differentiate into adipocytes or fibroblasts. This digressive differentiation potential, which is kept under tight control in the healthy muscle niche, contributes to fat and scar infiltrations in degenerative myopathies, such as in Duchenne Muscular Dystrophy (DMD). Controlling FAP differentiation by means of small molecules may contribute to delay the adverse consequences of the progressive pathological degeneration while offering, at the same time, a wider temporal window for gene therapy and cell-based strategies. In a high content phenotypic screening, we identified the immunosuppressant, azathioprine (AZA) as a negative modulator of FAP adipogenesis. We show here that AZA negatively affects the adipogenic propensity of FAPs purified from wild type and <jats:italic>mdx<\/jats:italic> mice by impairing the expression of the master adipogenic regulator, peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3). We show that this inhibition correlates with a decline in the activation of the AKT-mTOR axis, the main pathway that transduces the pro-adipogenic stimulus triggered by insulin. In addition, AZA exerts a cytostatic effect that has a negative impact on the mitotic clonal process that is required for the terminal differentiation of the preadipocyte-committed cells.<\/jats:p>","DOI":"10.1038\/s41598-019-39538-y","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T11:02:46Z","timestamp":1552474966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro\/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-7502","authenticated-orcid":false,"given":"Alessio","family":"Reggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0952-1710","authenticated-orcid":false,"given":"Marco","family":"Rosina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Massacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zuccotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fuoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Gargioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Castagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9528-6018","authenticated-orcid":false,"given":"Gianni","family":"Cesareni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"39538_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40610-015-0025-z","volume":"1","author":"D Dey","year":"2015","unstructured":"Dey, D., Goldhamer, D. J. & Yu, P. B. Contributions of Muscle-Resident Progenitor Cells to Homeostasis and Disease. Curr Mol Bio Rep 1, 175\u2013188 (2015).","journal-title":"Curr Mol Bio Rep"},{"key":"39538_CR2","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1242\/dev.067595","volume":"138","author":"C Lepper","year":"2011","unstructured":"Lepper, C., Partridge, T. A. & Fan, C.-M. An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 138, 3639\u20133646 (2011).","journal-title":"Development"},{"key":"39538_CR3","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1242\/dev.067587","volume":"138","author":"R Sambasivan","year":"2011","unstructured":"Sambasivan, R. et al. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 138, 3647\u20133656 (2011).","journal-title":"Development"},{"key":"39538_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/ncb2015","volume":"12","author":"AWB Joe","year":"2010","unstructured":"Joe, A. W. B. et al. Muscle injury activates resident fibro\/adipogenic progenitors that facilitate myogenesis. Nat. Cell Biol. 12, 153\u2013163 (2010).","journal-title":"Nat. Cell Biol."},{"key":"39538_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ncb2014","volume":"12","author":"A Uezumi","year":"2010","unstructured":"Uezumi, A., Fukada, S.-I., Yamamoto, N., Takeda, S. & Tsuchida, K. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat. Cell Biol. 12, 143\u2013152 (2010).","journal-title":"Nat. Cell Biol."},{"key":"39538_CR6","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1242\/dev.064162","volume":"138","author":"MM Murphy","year":"2011","unstructured":"Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A. & Kardon, G. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 138, 3625\u20133637 (2011).","journal-title":"Development"},{"key":"39538_CR7","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1242\/jcs.086629","volume":"124","author":"A Uezumi","year":"2011","unstructured":"Uezumi, A. et al. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. Journal of Cell Science 124, 3654\u20133664 (2011).","journal-title":"Journal of Cell Science"},{"key":"39538_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nm.3869","volume":"21","author":"DR Lemos","year":"2015","unstructured":"Lemos, D. R. et al. Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro\/adipogenic progenitors. Nat Med 21, 786\u2013794 (2015).","journal-title":"Nat Med"},{"key":"39538_CR9","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm1479","volume":"12","author":"GC Minetti","year":"2006","unstructured":"Minetti, G. C. et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 12, 1147\u20131150 (2006).","journal-title":"Nat Med"},{"key":"39538_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2119\/molmed.2011.00049","volume":"17","author":"S Consalvi","year":"2011","unstructured":"Consalvi, S. et al. Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases. Mol. Med. 17, 457\u2013465 (2011).","journal-title":"Mol. Med."},{"key":"39538_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2119\/molmed.2013.00011","volume":"19","author":"S Consalvi","year":"2013","unstructured":"Consalvi, S. et al. Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat. Mol. Med. 19, 79\u201387 (2013).","journal-title":"Mol. Med."},{"key":"39538_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/emmm.201202096","volume":"5","author":"C Mozzetta","year":"2013","unstructured":"Mozzetta, C. et al. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. Embo Mol Med 5, 626\u2013639 (2013).","journal-title":"Embo Mol Med"},{"key":"39538_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1101\/gad.234468.113","volume":"28","author":"V Saccone","year":"2014","unstructured":"Saccone, V. et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev. 28, 841\u2013857 (2014).","journal-title":"Genes Dev."},{"key":"39538_CR14","doi-asserted-by":"publisher","unstructured":"Spada, F. et al. Characterization by mass cytometry of different methods for the preparation of muscle mononuclear cells. N Biotechnol, https:\/\/doi.org\/10.1016\/j.nbt.2015.12.007 (2016).","DOI":"10.1016\/j.nbt.2015.12.007"},{"key":"39538_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/mus.880070903","volume":"7","author":"J Dangain","year":"1984","unstructured":"Dangain, J. & Vrbova, G. Muscle development in mdx mutant mice. Muscle Nerve 7, 700\u2013704 (1984).","journal-title":"Muscle Nerve"},{"key":"39538_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cell.2013.02.053","volume":"153","author":"JE Heredia","year":"2013","unstructured":"Heredia, J. E. et al. Type 2 innate signals stimulate fibro\/adipogenic progenitors to facilitate muscle regeneration. CELL 153, 376\u2013388 (2013).","journal-title":"CELL"},{"key":"39538_CR17","doi-asserted-by":"publisher","first-page":"45485","DOI":"10.1074\/jbc.M309069200","volume":"278","author":"P Dowell","year":"2003","unstructured":"Dowell, P., Otto, T. C., Adi, S. & Lane, M. D. Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways. J. Biol. Chem. 278, 45485\u201345491 (2003).","journal-title":"J. Biol. Chem."},{"key":"39538_CR18","doi-asserted-by":"publisher","first-page":"e6189","DOI":"10.1371\/journal.pone.0006189","volume":"4","author":"HH Zhang","year":"2009","unstructured":"Zhang, H. H. et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS ONE 4, e6189 (2009).","journal-title":"PLoS ONE"},{"key":"39538_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.taap.2013.07.024","volume":"272","author":"B Hern\u00e1ndez-Breijo","year":"2013","unstructured":"Hern\u00e1ndez-Breijo, B. et al. Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1. Toxicol. Appl. Pharmacol. 272, 568\u2013578 (2013).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"39538_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0543-5","volume":"13","author":"H-Y Huang","year":"2016","unstructured":"Huang, H.-Y., Chang, H.-F., Tsai, M.-J., Chen, J.-S. & Wang, M.-J. 6-Mercaptopurine attenuates tumor necrosis factor-\u03b1 production in microglia through Nur77-mediated transrepression and PI3K\/Akt\/mTOR signaling-mediated translational regulation. J Neuroinflammation 13, 78 (2016).","journal-title":"J Neuroinflammation"},{"key":"39538_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.nmd.2012.10.025","volume":"23","author":"T Ito","year":"2013","unstructured":"Ito, T. et al. Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors. Neuromuscul. Disord. 23, 349\u2013356 (2013).","journal-title":"Neuromuscul. Disord."},{"key":"39538_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1073\/pnas.0137044100","volume":"100","author":"Q-Q Tang","year":"2003","unstructured":"Tang, Q.-Q., Otto, T. C. & Lane, M. D. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. USA 100, 44\u201349 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"39538_CR23","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1073\/pnas.80.15.4856","volume":"80","author":"HM Blau","year":"1983","unstructured":"Blau, H. M., Webster, C. & Pavlath, G. K. Defective myoblasts identified in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 80, 4856\u20134860 (1983).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"39538_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","volume":"143","author":"A Sacco","year":"2010","unstructured":"Sacco, A. et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice. CELL 143, 1059\u20131071 (2010).","journal-title":"CELL"},{"key":"39538_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1432-0436.2001.680412.x","volume":"68","author":"A Asakura","year":"2001","unstructured":"Asakura, A., Komaki, M. & Rudnicki, M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68, 245\u2013253 (2001).","journal-title":"Differentiation"},{"key":"39538_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1369\/jhc.2010.956995","volume":"59","author":"JD Starkey","year":"2011","unstructured":"Starkey, J. D., Yamamoto, M., Yamamoto, S. & Goldhamer, D. J. Skeletal muscle satellite cells are committed to myogenesis and do not spontaneously adopt nonmyogenic fates. J. Histochem. Cytochem. 59, 33\u201346 (2011).","journal-title":"J. Histochem. Cytochem."},{"key":"39538_CR27","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2017.06.035","volume":"170","author":"D Kopinke","year":"2017","unstructured":"Kopinke, D., Roberson, E. C. & Reiter, J. F. Ciliary Hedgehog Signaling Restricts Injury-Induced Adipogenesis. CELL 170, 340\u2013351.e12 (2017).","journal-title":"CELL"},{"key":"39538_CR28","doi-asserted-by":"publisher","unstructured":"Marinkovic, M. et al. Skeletal muscle fibro-adipogenic progenitors of dystrophic mice are insensitive to NOTCH-dependent regulation of adipogenesis. 1\u201333, https:\/\/doi.org\/10.1101\/223370 (2017).","DOI":"10.1101\/223370"},{"key":"39538_CR29","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1212\/WNL.43.3_Part_1.520","volume":"43","author":"RC Griggs","year":"1993","unstructured":"Griggs, R. C. et al. Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months). Neurology 43, 520\u2013527 (1993).","journal-title":"Neurology"},{"key":"39538_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1212\/WNL.43.3_Part_1.532","volume":"43","author":"JT Kissel","year":"1993","unstructured":"Kissel, J. T. et al. Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy. Neurology 43, 532\u2013536 (1993).","journal-title":"Neurology"},{"key":"39538_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF02220605","volume":"43","author":"L Lennard","year":"1992","unstructured":"Lennard, L. The clinical pharmacology of 6-mercaptopurine. Eur. J. Clin. Pharmacol. 43, 329\u2013339 (1992).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"39538_CR32","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1182\/blood-2002-02-0495","volume":"100","author":"T Dervieux","year":"2002","unstructured":"Dervieux, T. et al. De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo. Blood 100, 1240\u20131247 (2002).","journal-title":"Blood"},{"key":"39538_CR33","first-page":"414","volume":"51","author":"S Hortelano","year":"1997","unstructured":"Hortelano, S. & Bosc\u00e1, L. 6-Mercaptopurine decreases the Bcl-2\/Bax ratio and induces apoptosis in activated splenic B lymphocytes. Mol. Pharmacol. 51, 414\u2013421 (1997).","journal-title":"Mol. Pharmacol."},{"key":"39538_CR34","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1172\/JCI16432","volume":"111","author":"I Tiede","year":"2003","unstructured":"Tiede, I. et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J. Clin. Invest. 111, 1133\u20131145 (2003).","journal-title":"J. Clin. Invest."},{"key":"39538_CR35","doi-asserted-by":"publisher","first-page":"24791","DOI":"10.1074\/jbc.M302167200","volume":"278","author":"P Ordentlich","year":"2003","unstructured":"Ordentlich, P., Yan, Y., Zhou, S. & Heyman, R. A. Identification of the antineoplastic agent 6-mercaptopurine as an activator of the orphan nuclear hormone receptor Nurr1. J. Biol. Chem. 278, 24791\u201324799 (2003).","journal-title":"J. Biol. Chem."},{"key":"39538_CR36","doi-asserted-by":"publisher","first-page":"24776","DOI":"10.1074\/jbc.M300088200","volume":"278","author":"KDSA Wansa","year":"2003","unstructured":"Wansa, K. D. S. A., Harris, J. M., Yan, G., Ordentlich, P. & Muscat, G. E. O. The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine. J. Biol. Chem. 278, 24776\u201324790 (2003).","journal-title":"J. Biol. Chem."},{"key":"39538_CR37","doi-asserted-by":"publisher","first-page":"43048","DOI":"10.18632\/oncotarget.17889","volume":"8","author":"AA Fern\u00e1ndez-Ramos","year":"2017","unstructured":"Fern\u00e1ndez-Ramos, A. A. et al. 6-mercaptopurine promotes energetic failure in proliferating T cells. Oncotarget 8, 43048\u201343060 (2017).","journal-title":"Oncotarget"},{"key":"39538_CR38","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0168-8278(01)00196-9","volume":"35","author":"AU Lee","year":"2001","unstructured":"Lee, A. U. & Farrell, G. C. Mechanism of azathioprine-induced injury to hepatocytes: roles of glutathione depletion and mitochondrial injury. J. Hepatol. 35, 756\u2013764 (2001).","journal-title":"J. Hepatol."},{"key":"39538_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1124\/jpet.104.069286","volume":"311","author":"C Menor","year":"2004","unstructured":"Menor, C. et al. Azathioprine acts upon rat hepatocyte mitochondria and stress-activated protein kinases leading to necrosis: protective role of N-acetyl-L-cysteine. J. Pharmacol. Exp. Ther. 311, 668\u2013676 (2004).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"39538_CR40","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/elps.201300137","volume":"35","author":"Y-E Cho","year":"2014","unstructured":"Cho, Y.-E., Moon, P.-G. & Baek, M.-C. An integrated proteomic and transcriptomic approach to understanding azathioprine- induced hepatotoxicity in rat primary hepatocytes. Electrophoresis 35, 911\u2013922 (2014).","journal-title":"Electrophoresis"},{"key":"39538_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).","journal-title":"Genome Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39538-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T07:29:19Z","timestamp":1671262159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39538-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["39538"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-39538-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]},"assertion":[{"value":"8 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4360"}}